期刊文献+

胃癌88例的临床治疗体会 被引量:4

下载PDF
导出
摘要 目的探讨胃癌患者治疗的临床疗效。方法回顾性分析收治的胃癌患者88例胃癌患者的临床资料。采用综合治疗及术前化疗、手术、术后化疗者共69例,姑息性手术19例。结果全组无手术死亡。术后并发症率15.9%(14/88),包括急性肾功能不全1例,切口感染3例,碱性反流性胃炎1例,术后出血1例,吻合口排空障碍2例,肺炎2例,心肌梗死1例,十二指肠残端瘘1例,营养不良2例,均经治疗后痊愈。术后79例获随访1—10年,在1~2年内因肝脏、肺、骨等远处转移或肿瘤复发死亡21例。根治性手术随访,3,5,10年生存率分别为69%,25%和6%。姑息性手术1,3,5年随访生存率为61%,28%,11%,≤6年为0。结论化疗-根治术-化疗等综合性治疗能提高生存率,改善患者生活质量。
作者 蔡云 周维
出处 《中国普通外科杂志》 CAS CSCD 2008年第2期199-201,共3页 China Journal of General Surgery
  • 相关文献

参考文献6

二级参考文献69

  • 1沈伟,郑磊贞,陈强,孙美兰.乐沙定为基础的化疗方案治疗晚期胃癌临床研究[J].肿瘤防治杂志,2004,11(4):403-404. 被引量:1
  • 2许东哲,朴东明,陈峻青.胃癌转移淋巴结漏诊的评价[J].中华肿瘤杂志,1995,17(4):292-293. 被引量:9
  • 3郝向东 杨秀梅 等.亚甲蓝胸腔内注射治疗癌性胸水[J].山东医药,1997,37(6):58-58.
  • 4Fujii M,Kochi M,Mochizuki F.Significance of neoadjuvant chemotherapy for gastric cancer [J].Gan To Kagaku Ryoho,2000,27(11):2028-2032.
  • 5Shchepotin IB,Chorny V,Hanfelt J,et al.Palliative superselective intraarterial chemotherapy for advanced nonresectable gastric cancer [J].J Gastrointest Surg,1999,3(4):426-431.
  • 6Lowy AM,Mansfield PF,Leach SD,et al.Response to neoadjuvant chemotherapy best predicts survival after curative resection of gastric cancer [J].Ann Surg,1999,229(3):303-308.
  • 7Ott K,Sendler A,Becker K,et al.Neoadjuvant chemotherapy with cisplatin,5-FU,and leucovorin(PLF) in locally advancel gastric cancer:a prospective phase Ⅱ study [J].Gastric Cancer,2003,6(3):159-167.
  • 8Persiani R,D'Ugo D,Rausei S,et al.Prognostic indicators in locally advanced gastric cancer(LAGC) treated with preoperative chemotherapy and D2-gastrectomy [J].J Surg Oncol,2005,89(4):227-236.
  • 9Cascinu S,Graziano F,Barni S,et al.A phase Ⅱ study of sequential chemotherapy with docetaxel after the weekly PELF regimen in advanced gastric cancer. A report from the Italian group for the study of digstive tract cancer [J].Br J Cancer,2001,84(4):470-474.
  • 10San W,Haller DG.Recent advances in the treatment of gastric cancer [J].Drug,2001,61(11):1545-1551.

共引文献58

同被引文献52

  • 1余佩武.腹腔镜胃癌手术的现状与进展[J].中国微创外科杂志,2005,5(7):512-514. 被引量:36
  • 2Reymond MA, Wittekind C, Jung A, et al. The incidence of portsite metastases might be reduced. Surg Endosc, 1997, 11 : 902 - 906.
  • 3Bouvy ND, Marquet Rl, Jeekel H, et al. Impact of gas (less) laparoscopy and laparotomy on peritoneal tumor growth and abdominal wall metastases. Ann Surg, 1996, 224 : 694 - 701.
  • 4Van Dam PA, Decloedt J, Tjalma WA, et al. Trocar implantation metastasis after laparoscopy in patients with advanced ovarian cancer: can the risk be reduced? Am J Obstet Gynecol, 1999, 181 : 536 - 541.
  • 5Ono S, Fujishiro M, Niimi K, et al. Technical feasibility of endoscopic submucosal dissection for early gastric cancer in pa- tients taking anti-coagulants or anti-platelet agents [ J ]. Dig Liver Dis ,2009,41 ( 10 ) :725 - 728.
  • 6Bozzetti F. Screening the nutritional status in oncology : a pre- liminary report on 1 , 000 outpatients [ J ]. Support Care Cancer, 2009,17(3) :279 -2g4.
  • 7Matsushia I, Hanai H, Kajimura M, et al. Should gastric cancer patients more than 80 years of age undergo surgery? Comparison with patients not treated surgically concerning prog- nosis and quality of life [ J ] . J Clin Gastroenterol, 2002, 35(1):29-34.
  • 8Butte JM, Duane 1, Cr0vari F, et al. Gastric cancer in pa- tients older than 75 years. Surgical treatment and long-term surcival [J]. Cir Esp, 2007, 82(6):341 -345.
  • 9Inaba T, lshikawa S, Toyokawa T, et al. Basal protrusion of ulcers induced by endoscopic submucosal dissection (ESD) during treatment with proton pump inhibitors , and the suppres- sive effects of polaprezinc. Hepatogastroenterology [ J ]. 2010, 57(99 - 100) :678 -784.
  • 10Dilege E, Mihmanli M, Demir U, et al. Prognostic value of preoperative CEA and CA 19 - 9 levels in reseetable gastric cancer[J]. Hepatogastrocnterology,2010,57(99 - 100) : 674 -677.

引证文献4

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部